| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |